International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-3
Original Article
TOPIC-Safety and Efficacy of Single Intramuscular Dose Dexmedetomidine for Pediatric Sedation for CT scans
 ,
 ,
 ,
Published
May 15, 2024
Abstract

Effective sedation is crucial for pediatric patients undergoing CT scans, however the use of intramuscular dexmedetomidine for this purpose hasn't been extensively explored. Our aim was to assess the efficacy and safety of intramuscular dexmedetomidine for sedation and anxiety relief during CT imaging in pediatric patients. We reviewed 30 cases of children aged 4-14 undergoing non-contrast CT Scan, who received single or multiple doses of 1 mcg/kg intramuscular dexmedetomidine to achieve a minimum Ramsay sedation score of 4.We analyzed patient demographics, diagnoses, vital signs, adverse events, and outcomes. Our findings indicate that all 30 children successfully underwent CT Scan under intramuscular dexmedetomidine sedation, with an average dose of 2.55±0.55 μg and an average time to achieve a minimum Ramsay sedation score of 4 of 14.07±0.88  minutes. Importantly, there were no significant changes in heart rates and mean arterial pressures from baseline values. In conclusion, intramuscular dexmedetomidine proves to be an effective and safe sedation option for pediatric patients undergoing non-contrast CT scan, offering an alternative approach that does not require intravenous access

Recommended Articles
Loading Image...
Volume-5, Issue-3
Citations
1112 Views
43 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved